Tue, October 29, 2019
Mon, October 28, 2019
Fri, October 25, 2019

Gregory Renza Initiated (APRE) at Buy and Held Target at $660 on, Oct 28th, 2019

Gregory Renza of RBC Capital, Initiated "Aprea Therapeutics, Inc." (APRE) at Buy and Held Target at $660 on, Oct 28th, 2019.

Gregory, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30